WEBOver the past few years, health groups have tapped CIDRAP to develop similar vaccine roadmaps for influenza, Zika virus, Nipah virus and Ebola/Marburg viruses. Michael T. Osterholm, PhD, MPH, CIDRAP's director, said current COVID-19 vaccines may not protect against future SARS-CoV-2 variants, and the threat of a novel virus spillover looms in ...